Company / Operating Cash Flow
GRAIL, Inc. Operating Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$299.0M
FY2025
5-year range
-$595.8M / -$299.0M
FY2022-FY2025
Trend
+48.2%
vs FY2024
Sector context
#162 of 164
Health Care
What the data says
Among 164 Health Care companies, GRAIL, Inc. is in the bottom 1% for operating cash flow. Improved from -$596M to -$299M over the past 2 years.
Based on SEC 10-K filings.
-$299M in FY2025.
Improved from -$596M to -$299M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 164This company -$299.0M Sector average $1.0B
▼
-128.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 48.2% year-over-year.
- Ranks #162 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$299.0M | +48.2% |
| FY2024 | -$577.2M | +3.1% |
| FY2023 | -$595.8M | -6.1% |
| FY2022 | -$561.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026